Updated Jul 16, 2026
Canton Barry is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $978K.
Canton Barry is noted as a 10% owner of Ginkgo Bioworks Holdings, Inc., a biotechnology company specializing in organism engineering. Specific details about his background and career are not widely available.
| Role | 10% Owner |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-13 | DNA | Ginkgo Bioworks Holdings, Inc. | S — Open-market sale | 124.7K | $6.43 | $802K |
| 2026-04-13 | DNA | Ginkgo Bioworks Holdings, Inc. | M — Option exercise | 251.8K | — | |
| 2026-04-10 | DNA | Ginkgo Bioworks Holdings, Inc. | S — Open-market sale | 13.1K | $6.40 | $84K |
| 2026-04-10 | DNA | Ginkgo Bioworks Holdings, Inc. | S — Open-market sale | 13.2K | $6.93 | $91K |
| 2026-04-10 | DNA | Ginkgo Bioworks Holdings, Inc. | M — Option exercise | 27.7K | — | |
| 2026-04-10 | DNA | Ginkgo Bioworks Holdings, Inc. | M — Option exercise | 27.7K | — |
Canton Barry is noted as a 10% owner of Ginkgo Bioworks Holdings, Inc., a biotechnology company specializing in organism engineering. Specific details about his background and career are not widely available.…
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($978K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Canton Barry profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.